Post Approval Continued Access Study of the MENTOR® Contour Profile Gel Breast Implant (NCT00811525) | Clinical Trial Compass
APPROVED_FOR_MARKETINGNot Applicable
Post Approval Continued Access Study of the MENTOR® Contour Profile Gel Breast Implant
Started 2004-08
Plain-language summary
The Contour Profile Gel Continued Access Study is designed to demonstrate safety of Mentor's Mammary Prostheses in women who are undergoing primary augmentation, primary reconstruction, or revision. Safety information on the rate of capsular contracture, rupture, and infection will be collected, and used to help determine device safety.
With approval of MemoryShapeâ„¢ Medium Height, Moderate Profile (CPG 321) Breast Implants on June 14, 2013, CPG CA Study subject enrollment has closed and the study has converted to a post approval study for this style.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subject is Genetic female and is at least 18 years old
* A candidate for:
* Primary breast augmentation (for general breast enlargement)
* Primary breast reconstruction (for cancer, trauma, surgical loss of breast or congenital deformity)
* Revision surgery (previous augmentation or reconstruction with silicone-filled or saline-filled implants)
* Signs the Informed Consent
* Agrees to return device to Mentor if device is explanted
* Agrees to comply with follow-up procedures, including returning for all follow-up visits
Exclusion Criteria:
* Subject is pregnant
* Has nursed a child within three months of study enrollment
* Been implanted with any silicone implant other than breast implants
* Confirmed diagnosis of rheumatic disease
* Currently has a condition that could compromise or complicate wound healing (except reconstruction subjects)
* Subject in Augmentation cohort and has diagnosis of active cancer of any type, except low-grade non-metastasizing skin cancer
* Infection or abscess anywhere in the body
* Demonstrates tissue characteristics which are clinically incompatible with implant (e.g. tissue damage resulting from radiation, inadequate tissue, or compromised vascularity)
* Possesses any condition, or is under treatment for any condition which, in the opinion of the investigator and/or consulting physicians(s), may constitute an unwarranted surgical risk.
* Anatomic or physiologic abnormality which could lead to significant postoper…